Ras as a target for treatment
K-Ras prenylation as a potential anticancer target
... successful Ras in- hibition merely based on changes of Erk ...by Ras proteins is indeed the Raf/Mek/Erk pathway, changes in Erk activation status not necessarily mirrors inhi- bition of ...bisphosphonate ...
15
NOGOB receptor mediated RAS signaling pathway is a target for suppressing proliferating hemangioma
... p53 target gene, and retinoblastoma (RB1) play negative regulatory roles in this process (36, ...upon treatment with either HRAS- or KRAS-specific siRNA, the G 1 phase distri- bution increased from ...
17
Identification of a ternary protein-complex as a therapeutic target for K-Ras-dependent colon cancer
... the treatment with PFD almost completely blocked the HCT116 xenograft ...PFD treatment also led to a significant growth inhibition at every time point after the drug administration (Figure ...
14
Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma
... towards Ras and nucleolin proteins, as a tool to disrupt the synergism between these three oncogenes as a potential treatment for ...To target nucleolin we used GroA, and to target Ras, ...
12
NF κB as potential target in the treatment of melanoma
... Combination strategies Abstract The RAS/MAP kinase pathway has attracted attention because activating mutations of the BRAF serine/threonine kinase was described in over 50% of melanomas. Very recently, selective ...
8
Molecules that target nucleophosmin for cancer treatment: an update
... A second strategy consists in interfering with the NPM1 protein-protein interaction network (Figure 4B). Data available in the literature [28, 90] and unpublished data from our laboratory, all suggest that protein ...
20
The role of mTOR as target for treatment of adrenal tumors
... over-activate other pro-growth pathways such us the Ras/Raf/MEK/ERK pathway (i.e. increased phosphorylation of ERK1/2), determining resistance or escape to the effects of traditional mTOR inhibitors.14, 29-31 We ...
208
EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
... interesting target for several biologic agents, mainly monoclonal anti- bodies (acting at the cellular surface level) and small mole- cules (inhibiting the intracellular tyrosine-kinase domain activity) ...
10
SHP2 phosphatase as a novel therapeutic target for melanoma treatment
... SHP2 is a key signal-transducer acting downstream of most receptor tyrosine kinases including EGFR, FGFR, c-MET, Kit, PDGFR, and insulin receptor, and positively regulates Ras/ERK1/2, PI3K/AKT, JAK/STAT, JNK, FAK, ...
13
Evaluation of the Mevalonate Pathway as a Target for the Treatment of Ovarian Cancer
... and Ras found in the cell membrane, suggesting that loss of prenylation may lead to an increase in the abundance of these small ...of Ras and Rho by statins has been observed previously (Mo and Elson, 2004; ...
288
Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer
... of RAS increases ...to target these mutations to improve outcomes in this ...preferentially target the cancer cells and spare normal ...preferentially target ATC in animal ...the ...
8
The neurotensin gene is a downstream target for Ras activation
... the Ras regulatory pathway plays a role in the expression of the neurotensin gene (NT/N), a terminally differentiated endocrine product specifically localized in the gastrointestinal tract to the adult small ...
10
RAS GTPase AS THE DRUG TARGET FOR ANTI CANCER DESIGNING OF DRUG FROM TEMPLATE
... ABSTRACT: Ras proteins in association with GTP and GDP act as a bio- molecular switch for signaling cell growth, cell survival and signal ...mutated Ras proteins is found to vary in different cancer types ...
5
Multibend-Center RAS / RAS
... / RAS 79.26-2 Multibend-Center Robotic blank loading The unique RAS robotic load- ing system uses an intelligent six axes robot? What does this mean? If you intend to process small batches or kits, program- ...
12
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
... pharmacological treatment in alcoholism has been demonstrated by a first wave of drugs which consists of 3 currently approved medications, the aldehyde dehydrogenase blocker disulfiram, the opioid antagonist ...
22
Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment
... A 76-year-old man with stage IV (T3aNxM1b) BRAF V600K–mutant melanoma presented for evaluation. Six years earlier he had received a diag- nosis of stage IIA melanoma on his neck that had been widely excised. One month ...
6
H-Ras and Its Oncogenic Mutants Ras G12V and Ras Q61L
... Upon binding of the GAP, the Switch I and Switch II regions become much more ordered. The P-loop is made of residues 11-14 and is involved with phosphate binding along with loops one, two, and four. Loops eight and ten ...
42
TYROSINE KINASE AS TARGET FOR CANCER TREATMENT
... these treatment was not ...molecular target, usually a protein with a critical role in tumor growth or ...oncologists target TKs for regulating cell growth and proliferation; through their inhibitors ...
15
Mesothelioma treatment: Are we on target? A review
... His translational scientific interests include the molecular diagnosis of mesothelioma and lung cancer and the evaluation of biomarkers of asbestos exposure and mesothelioma. He is or has been the study coordinator or ...
12
Outdoor Unit RAS-07PAVP-E RAS-10PAVP-E RAS-13PAVP-E RAS-16PAVP-E RAS-18PAVP-E. (North Europe Type)
... compressor motor, the outdoor unit controller controls speed of the compressor motor by controlling output voltage of the inverter and switching timing of the supply power (current tr[r] ...
114